217 related articles for article (PubMed ID: 10779324)
1. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins.
Yang L; Embree LJ; Hickstein DD
Mol Cell Biol; 2000 May; 20(10):3345-54. PubMed ID: 10779324
[TBL] [Abstract][Full Text] [Related]
2. Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing.
Yang L; Embree LJ; Tsai S; Hickstein DD
J Biol Chem; 1998 Oct; 273(43):27761-4. PubMed ID: 9774382
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
Chansky HA; Hu M; Hickstein DD; Yang L
Cancer Res; 2001 May; 61(9):3586-90. PubMed ID: 11325824
[TBL] [Abstract][Full Text] [Related]
4. The oncogenic TLS-ERG fusion protein exerts different effects in hematopoietic cells and fibroblasts.
Zou J; Ichikawa H; Blackburn ML; Hu HM; Zielinska-Kwiatkowska A; Mei Q; Roth GJ; Chansky HA; Yang L
Mol Cell Biol; 2005 Jul; 25(14):6235-46. PubMed ID: 15988032
[TBL] [Abstract][Full Text] [Related]
5. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
Prasad DD; Ouchida M; Lee L; Rao VN; Reddy ES
Oncogene; 1994 Dec; 9(12):3717-29. PubMed ID: 7970732
[TBL] [Abstract][Full Text] [Related]
6. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.
Rapp TB; Yang L; Conrad EU; Mandahl N; Chansky HA
J Orthop Res; 2002 Jul; 20(4):723-9. PubMed ID: 12168660
[TBL] [Abstract][Full Text] [Related]
7. Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).
Ichikawa H; Shimizu K; Katsu R; Ohki M
Mol Cell Biol; 1999 Nov; 19(11):7639-50. PubMed ID: 10523652
[TBL] [Abstract][Full Text] [Related]
8. EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing.
Yang L; Chansky HA; Hickstein DD
J Biol Chem; 2000 Dec; 275(48):37612-8. PubMed ID: 10982800
[TBL] [Abstract][Full Text] [Related]
9. Characterization and expression of the human gene encoding two translocation liposarcoma protein-associated serine-arginine (TASR) proteins.
Clinton JM; Chansky HA; Odell DD; Zielinska-Kwiatkowska A; Hickstein DD; Yang L
Gene; 2002 Feb; 284(1-2):141-7. PubMed ID: 11891055
[TBL] [Abstract][Full Text] [Related]
10. The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins.
Perani M; Antonson P; Hamoudi R; Ingram CJ; Cooper CS; Garrett MD; Goodwin GH
J Biol Chem; 2005 Dec; 280(52):42863-76. PubMed ID: 16227627
[TBL] [Abstract][Full Text] [Related]
11. TLS-ERG leukemia fusion protein deregulates cyclin-dependent kinase 1 and blocks terminal differentiation of myeloid progenitor cells.
Pan J; Zou J; Wu DY; Roberson RS; Hennings LJ; Ma X; Yared M; Blackburn ML; Chansky HA; Yang L
Mol Cancer Res; 2008 May; 6(5):862-72. PubMed ID: 18505930
[TBL] [Abstract][Full Text] [Related]
12. Temperature-dependent localization of TLS-CHOP to splicing factor compartments.
Göransson M; Wedin M; Aman P
Exp Cell Res; 2002 Aug; 278(2):125-32. PubMed ID: 12169268
[TBL] [Abstract][Full Text] [Related]
13. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
Kong XT; Ida K; Ichikawa H; Shimizu K; Ohki M; Maseki N; Kaneko Y; Sako M; Kobayashi Y; Tojou A; Miura I; Kakuda H; Funabiki T; Horibe K; Hamaguchi H; Akiyama Y; Bessho F; Yanagisawa M; Hayashi Y
Blood; 1997 Aug; 90(3):1192-9. PubMed ID: 9242552
[TBL] [Abstract][Full Text] [Related]
14. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.
Panagopoulos I; Lassen C; Isaksson M; Mitelman F; Mandahl N; Aman P
Oncogene; 1997 Sep; 15(11):1357-62. PubMed ID: 9315104
[TBL] [Abstract][Full Text] [Related]
15. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation.
Ichikawa H; Shimizu K; Hayashi Y; Ohki M
Cancer Res; 1994 Jun; 54(11):2865-8. PubMed ID: 8187069
[TBL] [Abstract][Full Text] [Related]
16. Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II.
Immanuel D; Zinszner H; Ron D
Mol Cell Biol; 1995 Aug; 15(8):4562-71. PubMed ID: 7623847
[TBL] [Abstract][Full Text] [Related]
17. Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22).
Panagopoulos I; Aman P; Fioretos T; Höglund M; Johansson B; Mandahl N; Heim S; Behrendtz M; Mitelman F
Genes Chromosomes Cancer; 1994 Dec; 11(4):256-62. PubMed ID: 7533529
[TBL] [Abstract][Full Text] [Related]
18. Multiple functional domains of the oncoproteins Spi-1/PU.1 and TLS are involved in their opposite splicing effects in erythroleukemic cells.
Delva L; Gallais I; Guillouf C; Denis N; Orvain C; Moreau-Gachelin F
Oncogene; 2004 May; 23(25):4389-99. PubMed ID: 15064749
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS.
Hallier M; Lerga A; Barnache S; Tavitian A; Moreau-Gachelin F
J Biol Chem; 1998 Feb; 273(9):4838-42. PubMed ID: 9478924
[TBL] [Abstract][Full Text] [Related]
20. Identification of an RNA binding specificity for the potential splicing factor TLS.
Lerga A; Hallier M; Delva L; Orvain C; Gallais I; Marie J; Moreau-Gachelin F
J Biol Chem; 2001 Mar; 276(9):6807-16. PubMed ID: 11098054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
